1. Adynamic Bone Decreases Bone Toughness During Aging by Affecting Mineral and Matrix. (6th October 2015) Authors: Ng, Adeline H; Omelon, Sidney; Variola, Fabio; Allo, Bedilu; Willett, Thomas L; Alman, Benjamin A; Grynpas, Marc D Journal: Journal of bone and mineral research Issue: Volume 31:Number 2(2016:Feb.) Page Start: 369 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Growth Hormone Increases Bone Toughness and Decreases Muscle Inflammation in Glucocorticoid‐Treated Mdx Mice, Model of Duchenne Muscular Dystrophy. (12th June 2019) Authors: Yoon, Sung‐Hee; Grynpas, Marc D; Mitchell, Jane Journal: Journal of bone and mineral research Issue: Volume 34:Number 8(2019) Page Start: 1473 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. In Vivo Bone Effects of a Novel Bisphosphonate‐EP4a Conjugate Drug (C3) for Reversing Osteoporotic Bone Loss in an Ovariectomized Rat Model. (9th November 2019) Authors: Sheikh, Zeeshan; Chen, Gang; Al‐Jaf, Faik; Thévenin, Marion; Banks, Kate; Glogauer, Michael; Young, Robert N; Grynpas, Marc D Journal: JBMR plus Issue: Volume 3:Number 12(2019) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Increased osteoblast GαS level determines bone response to hyperparathyroidism in female mice. Issue 1 (31st May 2022) Authors: Zhang, Lucia; Lee, Kathy K; Sugamori, Kim S; Grynpas, Marc D; Mitchell, Jane Journal: Journal of endocrinology Issue: Volume 254:Issue 1(2022) Page Start: 13 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Novel EP4 Receptor Agonist‐Bisphosphonate Conjugate Drug (C1) Promotes Bone Formation and Improves Vertebral Mechanical Properties in the Ovariectomized Rat Model of Postmenopausal Bone Loss. (April 2015) Authors: Liu, Careesa C; Hu, Sally; Chen, Gang; Georgiou, John; Arns, Steve; Kumar, Nag S; Young, Robert N; Grynpas, Marc D Journal: Journal of bone and mineral research Issue: Volume 30:Number 4(2015:Apr.) Page Start: 670 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Overexpression of GαS in Murine Osteoblasts In Vivo Leads to Increased Bone Mass and Decreased Bone Quality. (10th August 2017) Authors: Zhang, Lucia; Sugamori, Kim S; Claridge, Colin; dela Cruz, Ariana; Grynpas, Marc D; Mitchell, Jane Journal: Journal of bone and mineral research Issue: Volume 32:Number 11(2017:Nov.) Page Start: 2171 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Targeting therapeutics to bone by conjugation with bisphosphonates. (June 2018) Authors: Young, Robert N; Grynpas, Marc D Journal: Current opinion in pharmacology Issue: Volume 40(2018) Page Start: 87 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. The CRH‐Transgenic Cushingoid Mouse Is a Model of Glucocorticoid‐Induced Osteoporosis. (28th June 2017) Authors: Williams‐Dautovich, Jasmine; Yogendirarajah, Keertika; Dela Cruz, Ariana; Patel, Rucha; Tsai, Ricky; Morgan, Stuart A; Mitchell, Jane; Grynpas, Marc D; Cummins, Carolyn L Journal: JBMR plus Issue: Volume 1:Number 1(2017) Page Start: 46 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗